Company
About us
History
Leadership
Location
SCIENCE
PIPELINE
ACART
PUBLICATION
INVESTORS
Notice
Financial Info
IR Material
Press Releases
Public Disclosures
SUSTAINABILITY
Governance
Code of Ethics
Board
Committee
Audit
Articles of Inc.
ESG Portal
Contact
Contact us
Report a Concern
Privacy Policy
Careers
a
English
M
English
COMPANY
About us
History
Leadership
Location
SCIENCE
PIPELINE
ACART
Publication
INVESTORS
Notice
Financial Info
IR Material
Press Releases
Public Disclosures
Sustainability
Governance
Code of Ethics
Board
Committee
Audit
Articles of Inc.
ESG Portal
CONTACT
Contact us
Report a Concern
Privacy Policy
Careers
English
May 2, 2025
Oscotec wins FDA nod for anti-resistance cancer trial, drops oral denfivontinib over safety issues
By: Oscotec oscotec2026
Attachment File
